Hilar cholangiocarcinoma: Surgical and endoscopic approaches

Surgical Clinics of North America

Volumn 84, Issue 2, 2004, Pages 525-542

  Bold, Richard J ^a   Goodnight Jr , James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

BILE DUCT CARCINOMA; BILE LEAKAGE; BLEEDING; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; HUMAN; LIVER HILUS; LIVER SURGERY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOGRAPHY; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; LYMPH NODE EXCISION; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PALLIATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642290647     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00232-9     Document Type: Review

References (74)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics 2003. CA Cancer J Clin. 53:(1):2003;5-26.
2. Jarnagin W. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol. 19:2000;156-176.
3. Yoon J., Gores G. Diagnosis, staging, and treatment of cholangiocarcinoma. Curr Treat Options Gastroenterol. 6:(2):2003;105-112.
4. Chamberlain R., Blumgart L. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol. 7:(1):2000;55-66.
5. Figueras J., Llado L., Valls C., Serrano T., Ramos E., Fabregat J., et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl. 6:(6):2000;786-794.
6. Nakeeb A., Pitt H., Sohn T., Coleman J., Abrams R., Piantadosi S., et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 224:(4):1996;463-475.
7. Garg P., Tandon R. Preoperative assessment of cholangiocarcinoma: meeting the challenge. J Gastroenterol Hepatol. 14:1999;615-617.
8. Szklaruk J., Tamm E., Charnsangavej C. Preoperative imaging of biliary tract cancers. Surg Oncol Clin N Am. 11:2002;865-876.
9. Hann L., Winston C., Brown K., Akhurst T. Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy. Semin Surg Oncol. 19:2000;94-115.
10. Burke E.C., Jarnagin W.R., Hochwald S.N., Pisters P.W., Fong Y., Blumgart L.H. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 228:(3):1998;385-394.
11. Garg P.K., Tandon R.K. Preoperative assessment of cholangiocarcinoma: meeting the challenge. J Gastroenterol Hepatol. 14:(7):1999;615-617.
12. Nakeeb A., Tran K., Black M., Erickson B., Ritch P., Quebbeman E., et al. Improved survival in resected biliary malignancies. Surgery. 132:2002;555-564.
13. Kosuge T., Yamamoto J., Shimada K., Yamasaki S., Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 230:(5):1999;663-671.
14. Lee S., Lee Y., Park K., Hwang S., Min P. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg. 7:2000;135-141.
15. Nimura Y., Kamiya J., Kondo S., Nagino M., Uesaka K., Oda K., et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 7:2000;155-162.
16. Launois B., Reding R., Lebeau G., Buard J. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg. 7:2000;128-134.
17. Gazzaniga G., Filauro M., Bagarolo C., Mori L. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg. 7:2000;122-127.
18. Jarnagin W., Fong Y., DeMatteo R., Gonen M., Burke E., Bodniewicz J., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 234:(4):2001;507-519.
19. Neuhaus P., Jonas S. Surgery for hilar cholangiocarcinoma - the German experience. J Hepatobiliary Pancreat Surg. 7:2000;142-147.
20. Saldinger P., Blumgart L. Resection of hilar cholangiocarcinoma - a European and United States experience. J Hepatobiliary Pancreat Surg. 7:2000;111-114.
21. Tabata M., Kawarada Y., Yokoi H., Higashiguchi T., Isaji S. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 7:2000;148-154.
22. Lillemoe K., Cameron J. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg. 7:2000;115-121.
23. Capussotti L., Muratore A., Polastri R., Ferrero A., Massucco P. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg. 195:(5):2002;641-647.
24. Tamada K., Yasuda Y., Nagai H., Tomiyama T., Tano S., Kanai N., et al. Limitation of cholangiography in assessing longitudinal spread of extrahepatic bile duct carcinoma to the hepatic side. J Gastroenterol Hepatol. 14:1999;691-698.
25. Semelka R.C., Shoenut J.P., Kroeker M.A., Hricak H., Minuk G.Y., Yaffe C.S., et al. Bile duct disease: prospective comparison of ERCP, CT, and fat suppression MRI. Gastrointest Radiol. 17:(4):1992;347-352.
26. Lynn R.B., Wilson J.A., Cho K.J. Cholangiocarcinoma. Role of percutaneous transhepatic cholangiography in determination of resectability. Dig Dis Sci. 33:(5):1988;587-591.
27. Hatfield A.R., Tobias R., Terblanche J., Girdwood A.H., Fataar S., Harries-Jones R., et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 2:(8304):1982;896- 899.
28. McPherson G.A., Benjamin I.S., Hodgson H.J., Bowley N.B., Allison D.J., Blumgart L.H. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 71:(5):1984;371-375.
29. Hochwald S.N., Burke E.C., Jarnagin W.R., Fong Y., Blumgart L.H. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 134:(3):1999;261-266.
30. Schwarz R.E. Technical considerations to maintain a low frequency of postoperative biliary stent-associated infections. J Hepatobiliary Pancreat Surg. 9:(1):2002;93-97.
31. Sohn T.A., Yeo C.J., Cameron J.L., Pitt H.A., Lillemoe K.D. Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg. 4:(3):2000;258-267.
32. Heslin M.J., Brooks A.D., Hochwald S.N., Harrison L.E., Blumgart L.H., Brennan M.F. A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg. 133:(2):1998;149-154.
33. Pisters P.W., Hudec W.A., Hess K.R., Lee J.E., Vauthey J.N., Lahoti S., et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy- associated morbidity in 300 consecutive patients. Ann Surg. 234:(1):2001;47-55.
34. Kalra M., Sahani D., Ahmad A., Saini S. The role of magnetic resonance cholangiopancreatography in patients with suspected biliary obstruction. Curr Gastroenterol Rep. 4:(2):2002;160-166.
35. Lopera J.E., Soto J.A., Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology. 220:(1):2001;90-96.
36. Georgopoulos S.K., Schwartz L.H., Jarnagin W.R., Gerdes H., Breite I., Fong Y., et al. Comparison of magnetic resonance and endoscopic retrograde cholangiopancreatography in malignant pancreaticobiliary obstruction. Arch Surg. 134:(9):1999;1002-1007.
37. Yeh T.S., Jan Y.Y., Tseng J.H., Chiu C.T., Chen T.C., Hwang T.L., et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol. 95:(2):2000;432-440.
38. Pavone P., Laghi A., Passariello R. MR cholangiopancreatography in malignant biliary obstruction. Semin Ultrasound CT MR. 20:(5):1999;317-323.
39. Yeh T., Jan Y., Tseng J., Chiu C., Chen T., Hwang T., et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol. 95:(2):1993;432-440.
40. Zidi S., Prat F., Guen O., Rondeau Y., Pelletier G. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut. 46:2000;103-106.
41. Harisinghani M., Hahn P. Computed tomography and magnetic resonance imaging evaluation of liver cancer. Gastroenterol Clin North Am. 31:2002;759-776.
42. Worawattanakul S., Semelka R., Noone T., Calvo B., Kelekis N., Woosley J. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. J Magn Reson Imaging. 16:(9):1998;993-1003.
43. Choi B.I., Kim T.K., Han J.K. MRI of clonorchiasis and cholangiocarcinoma. J Magn Reson Imaging. 8:(2):1998;359-366.
44. Koslin D. Update on gastrointestinal imaging. Rev Gastroenterol Disord. 2:(1):2002;3-10.
45. Hann L., Winston C., Brown K., Akhurst T. Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy. Semin Surg Oncol. 29:2000;94-115.
46. Bombardieri E., Aliberti G., De Graaf C., Pauwels E., Crippa F. Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer. Semin Surg Oncol. 20:2001;134-146.
47. 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med. 29:(8):2002;1047-1054.
48. Fritscher-Ravens A., Bohuslavizki K., Broering D., Jenicke L., Schäfer H., Buchert R., et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun. 22:2001;1277-1285.
49. Kluge R., Schmidt F., CaCa K., Barthel H., Hesse S., Georgi P. Positron emission tomography with [(18)F] fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology. 33:(5):2001;1029-1035.
50. Vollmer C., Drebin J., Middleton W., Teefey S., Linehan D., Soper N., et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg. 235:(1):2002;1-7.
51. Weber S., DeMatteo R., Fong Y., Blumgart L., Jarnagin W. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg. 235:(3):2002;392-399.
52. D'Angelica M., Fong Y., Weber S., Gonen M., DeMatteo R., Conlon K. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol. 10:(2):2003;183-189.
53. American Joint Commission on Cancer. AJCC cancer staging manual. 5th edition:1997;Lipincott-Raven, Philadelphia.
54. Bismuth H., Corlett M.B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. SGO. 140:1975;170-178.
55. Sarmiento J., Nagorney D. Hepatic resection in the treatment of perihilar cholangiocarcinoma. Surg Oncol Clin N Am. 11:2002;893-908.
56. Nimura Y., Haykawa N., Kamiya J., Kondo S., Nagino M., Kania M. Hilar cholangiocarcinoma - surgical anatomy and curative resection. J Hepatobiliary Pancreat Surg. 2:1995;239-248.
57. Tsao J.I., Nimura Y., Kamiya J., Hayakawa N., Kondo S., Nagino M., et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 232:(2):2000;166-174.
58. Nimura Y., Hayakawa N., Kamiya J., Kondo S., Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 14:(4):1990;535-543.
59. Hanazaki K., Kajikawa S., Shimozawa N., Shimada K., Hiraguri M., Koide N., et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology. 49:(44):2002;311-316.
60. Dimick J.B., Cowan J.A. Jr., Knol J.A., Upchurch G.R. Jr. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg. 138:(2):2003;185-191.
61. Begg C.B., Cramer L.D., Hoskins W.J., Brennan M.F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 280:(20):1998;1747-1751.
62. Birkmeyer J.D., Siewers A.E., Finlayson E.V., Stukel T.A., Lucas F.L., Batista I., et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 346:(15):2002;1128-1137.
63. Dimick J.B., Pronovost P.J., Cowan J.A. Jr., Lipsett P.A. Postoperative complication rates after hepatic resection in Maryland hospitals. Arch Surg. 138:(1):2003;41-46.
64. Munoz L., Roayaie S., Maman D., Fishbein T., Sheiner P., Emre S., et al. Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg. 9:(2):2002;237-241.
65. Kitagawa Y., Nagino M., Kamiya J., Uesaka K., Sano T., Yamamoto H., et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 233:(3):2001;385-392.
66. Luman W., Cull A., Palmer K. Quality of life in patients stented for malignant biliary obstructions. Eur J Gastroenterol Hepatol. 9:(5):1997;481-484.
67. Madoff D., Wallace M. Palliative treatment of unresectable bile duct cancer. Which stent? Which approach? Surg Oncol Clin N Am. 11:2002;923-939.
68. Cowling M., Adam A. Internal stenting in malignant biliary obstruction. World J Surg. 25:2001;355-361.
69. Born P., Rosch T., Bruhl K., Sandschin W., Weigert N., Ott R., et al. Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol. 38:(6):2000;483-489.
70. Kuvshinoff B., Armstrong J., Fong Y., Schupak K., Getradjman G., Heffernan N., et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg. 82:(11):1995;1522-1525.
71. Gerhards M., den Hartog D., Rauws E., van Gulik T., Gonzalez G., Lamaeris J., et al. Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma. Eur J Surg. 167:(4):2002;274-280.
72. Rumalla A., Baron T. Evaluation and endoscopic palliation of cholangiocarcinoma. Management of cholangiocarcinoma. Dig Dis. 17:(4):1999;194-200.
73. Cheng J., Bruno M., Bergman J., Rauws E., Tytgat G., Huibregtse K. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointestinal Endoscopy. 56:2002;33-39.
74. Ahrendt S.A., Nakeeb A., Pitt H.A. Cholangiocarcinoma. Clin Liver Dis. 5:(1):2001;191-218.